MedComm

MedComm is interested in topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology and artificial intelligence. The journal focuses on clinical and experimental advances on disease characteristics, pathogenic mechanism and medical techniques. Topics of interest include, but are not limited to: • Epigenetics, genomics, proteomics and metabonomics • Non-coding RNA in disease • Cell senescence and cell death • Cellular signal transduction • Gene therapy and gene editing • Cancer immunology and immunotherapy • Structural biology, chemical genomics and drug discovery • High-definition imaging • Artificial intelligence in medicine • Stem cells and regenerative medicine • Nanomedicine and drug delivery system • Early disease diagnosis and biomarkers • Clinical trials evaluating new treatments for cancer or other diseases